Targeting the Fas/FasL signaling pathway in cancer therapy. (Q37975245)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 12 January 2012

Language	Label	Description	Also known as
English	Targeting the Fas/FasL signaling pathway in cancer therapy.	scientific article published on 12 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Targeting the Fas/FasL signaling pathway in cancer therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

María Villa-Morales

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

José Fernández-Piqueras

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

12 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Expert Opinion on Therapeutic Targets

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

85-101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239437%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

The role of FasL and Fas in health and disease.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Molecular ordering of the initial signaling events of CD95.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Biology of FasL.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Defining CD95 as a tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

From cancer immunosurveillance to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Creating immune privilege: active local suppression that benefits friends, but protects foes.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

mRNA expression of variant Fas molecules in acute leukemia cells.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Mutations in apoptosis genes: a pathogenetic factor for human disease

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL)

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

An elaborate pathway required for Ras-mediated epigenetic silencing

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Epigenetic changes in tumor Fas levels determine immune escape and response to therapy

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

microRNAs and death receptors.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Overcoming drug resistance by enhancing apoptosis of tumor cells.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

IAP proteins: blocking the road to death's door

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Protective effects of HFE7A, mouse anti-human/mouse Fas monoclonal antibody against acute and lethal hepatic injury induced by Jo2

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Highly frequent anti-idiotype antibody in cynomolgus monkeys developed against mouse-derived regions of anti-Fas antibody humanized by complementarity determining region grafting

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Construction of optimized bispecific antibodies for selective activation of the death receptor CD95.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

A Fas agonist induces high levels of apoptosis in haematological malignancies

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted Activation

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

CTLA-4 . FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

A CD40–CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

CD40·FasL and CTLA-4·FasL Fusion Proteins Induce Apoptosis in Malignant Cell Lines by Dual Signaling

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Fas and mutant estrogen receptor chimeric gene: a novel suicide vector for tamoxifen-inducible apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Microbial-based therapy of cancer: current progress and future prospects

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Inhibition of tumor growth using salmonella expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Death receptors: targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Novel role of thiadiazolidine derivatives in inducing cell death through Myc-Max, Akt, FKHR, and FasL pathway.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Paclitaxel (Taxol)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L).

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Understanding rituximab function and resistance: implications for tailored therapy.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Clustering of hypermethylated genes in neuroblastoma

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Combination of human Fas (CD95/Apo-1) ligand with adriamycin significantly enhances the efficacy of antitumor response

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.628937

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37975245&oldid=1562126337"